143 related articles for article (PubMed ID: 35641267)
1. Recurrent Mandibular Giant Cell Lesion in Neurofibromatosis Type 1: Second Hit Mutation on the
Friedrich RE; Luebke AM; Schüller U; Hagel C; Kohlrusch FK; Wieland I; Zenker M
Anticancer Res; 2022 Jun; 42(6):2945-2952. PubMed ID: 35641267
[TBL] [Abstract][Full Text] [Related]
2. Recurrent multilocular mandibular giant cell granuloma in neurofibromatosis type 1: Evidence for second hit mutation of NF1 gene in the jaw lesion and treatment with curettage and bone substitute materials.
Friedrich RE; Grob TJ; Hollants S; Zustin J; Spaepen M; Mautner VF; Luebke AM; Hagel C; Legius E; Brems H
J Craniomaxillofac Surg; 2016 Aug; 44(8):1054-60. PubMed ID: 27316856
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.
Friedrich RE; Zustin J; Luebke AM; Rosenbaum T; Gosau M; Hagel C; Kohlrusch FK; Wieland I; Zenker M
In Vivo; 2021; 35(3):1711-1736. PubMed ID: 33910856
[TBL] [Abstract][Full Text] [Related]
4. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
Sabol Z; Kipke-Sabol L
Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
[TBL] [Abstract][Full Text] [Related]
5. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
[TBL] [Abstract][Full Text] [Related]
6. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.
Stewart DR; Brems H; Gomes AG; Ruppert SL; Callens T; Williams J; Claes K; Bober MB; Hachen R; Kaban LB; Li H; Lin A; McDonald M; Melancon S; Ortenberg J; Radtke HB; Samson I; Saul RA; Shen J; Siqveland E; Toler TL; van Maarle M; Wallace M; Williams M; Legius E; Messiaen L
Genet Med; 2014 Jun; 16(6):448-59. PubMed ID: 24232412
[TBL] [Abstract][Full Text] [Related]
7. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
8. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in tumor cells of a recurrent mandibular giant cell granuloma in neurofibromatosis type 1.
Friedrich RE; Mautner VF; Scheuer HA
Anticancer Res; 2007; 27(4A):2079-83. PubMed ID: 17649825
[TBL] [Abstract][Full Text] [Related]
10. The pathoetiology of neurofibromatosis 1.
Jouhilahti EM; Peltonen S; Heape AM; Peltonen J
Am J Pathol; 2011 May; 178(5):1932-9. PubMed ID: 21457932
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
[TBL] [Abstract][Full Text] [Related]
12. Central giant-cell granuloma in a patient with neurofibromatosis type 1: 7 years of follow-up.
Garrido MB; Jagtap R; Matesi CD; Diaz V; Hardeman J; Gohel A
J Korean Assoc Oral Maxillofac Surg; 2024 Feb; 50(1):49-55. PubMed ID: 38419521
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.
Serra E; Puig S; Otero D; Gaona A; Kruyer H; Ars E; Estivill X; Lázaro C
Am J Hum Genet; 1997 Sep; 61(3):512-9. PubMed ID: 9326316
[TBL] [Abstract][Full Text] [Related]
14. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg.
Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M
Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640
[TBL] [Abstract][Full Text] [Related]
15. Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers.
Wiest V; Eisenbarth I; Schmegner C; Krone W; Assum G
Hum Mutat; 2003 Dec; 22(6):423-7. PubMed ID: 14635100
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.
Laycock-van Spyk S; Thomas N; Cooper DN; Upadhyaya M
Hum Genomics; 2011 Oct; 5(6):623-90. PubMed ID: 22155606
[TBL] [Abstract][Full Text] [Related]
17. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
[TBL] [Abstract][Full Text] [Related]
18. Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1.
Edwards PC; Fantasia JE; Saini T; Rosenberg TJ; Sachs SA; Ruggiero S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec; 102(6):765-72. PubMed ID: 17138179
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1.
Sant DW; Margraf RL; Stevenson DA; Grossmann AH; Viskochil DH; Hanson H; Everitt MD; Rios JJ; Elefteriou F; Hennessey T; Mao R
J Med Genet; 2015 Apr; 52(4):256-61. PubMed ID: 25612910
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
